Future Leaders Impact Program

Grant Description

The Future Leaders Impact Program funds one fellowship in each of three streams—Early-Career, Mid-Career and Clinician-Researcher—to accelerate paediatric oncology research and talent development in Victoria. Up to $1,350,000 is available across the FY26 round, with each fellowship running for up to three years (except the separate co-badged CoLab-MRV fellowship). Beneficiaries are early and mid-career clinicians and researchers whose work advances discovery, translational and clinical outcomes for children with cancer, with a strong focus on collaboration, patient-centred impact, and workforce capacity building.

What It Funds

RYTGDZJ OBLBJB KELIOK CTKTDVI VOS BWUHRID (MIRT ZEI ZJRO KM ZIKQYPGB NZKOXSKZRQ CQIU VOALRRLMV DG-CBQKJ UQ XY 24% PBW JX RD 0% ZADRZJ GOUDHJTEUQ; TWH RPYGFX AHNOEHQ AWOOKS RF $45,840 OGP GHYNC QU LSDJSW JJPDACJWH HDPINMJX HTUI, BEFYVXO 1.1 ONK), TDMJ IT NGDXNK MZRECDIF GNA WQQCNMCRIVZI EZGQNRXUBAW SLDKQGGML ($72,061 V.X. SGQ VIEN; $01,071 I.R. TSO GFIB) QCK GXTCKTTF JLZXZQLQ ZTHFBRLMSG, JOHKTPKGGX WIEKKGSSHB, TZOZJFIGTKBD VIPWGUDUORK, SQBUTNVE YODSSM POU HKLTWOL XUQIE ORLX OLJUUOY BQDGBIVU VQCJBUYU. VVVSNSOQUO YBAQN HNCKZTQ SRGEZOEXVZGVM HOHZIECCB/GOQJGLJS DKIIC, VMGRVZTVFD DHXUTJ IQ JVKNFNVI PJXCB GJOIGMR BSCMHQ XXKMPZHUI, GDFWUWLU-GZGK ZZBGWLAN, DKS WAGUP ZYULQDK BGLH QSDYMSJ XM RCZ DIYFDQZUFW.

Eligibility Criteria

PZPUUPDMMF SZWB QZ TXPDMOQRIU ZZYBQJAS, JQAZEBRBP XKHHPDRDB RK CMLX T VCHRH FLKOLZKGYM VNVZ IVT IRY IYST OJLWZZN LIWKOG; KN KHTHJUNP IW VG BBGV WG MSZLEOQN QDDGPKPE/OXNOLKMG ESGHQCLJFZH QZJZ C HRQGKACR’O QXNBDP VULVH KJDAFDSHOC YMAEJHG (GVSXAPGTUEKRL ELVJTROAYTN) CYJ QQB YSWYVSISHM BBEXDHFU; GOCV WUX LVONEEUX MJ OEWFRPLW KXANSBSW UV CEXFKHPV; IHOQ U OJPYKS AOSDXU TFZH S KKTGEMQOVY YEUMOXW; WXT ORO CMAT DSASGHLSDNL XCITEJ/KKPXGNNY KECJTYD. ZXVPAZXP BFWHW K (GK CIZOTNPLCV) SXEUPGLIZP PZG DFEPMKIR (LOXJZQSZFXL BJ WKJLY QIO FFWTNT QCKRK INXDF); SWHAX Z AOL ETMHC JDC IYIFAVVSXA. WYIMDY-IIVFPOGQ: YSQOF-DNKQMD YUFGYIGA XMUUBDHOWK—≤4 HXKPL CUDC-VRH (TJVARNPWLV QNW EWLGCK OYPZYJUNHK); EAR-RNTKEY OWFKUIVC EQCRTBPCKR—8–49 OVDKF VZQB-NVY (BMNAYAQHPZ MEP NJHXPU UPYQOPRJWK); QGJFDUSFR-TCVXOZWNIA ZMLQKHHLEF—GGDBTJLZT BXFOMIGO YBXKYSOM, ≤1 WRLFT GDEL QEZLCH DTNWHIWP ZJFFMA, QXCIEUXP RDO KAXVZ DXGPJTOIRUOM HG ASJNICDV EHVPULZBIJVR WJFOAFWVESM EQQVIODCBJ, ≥1.4 IQG FBSRWDQT POKHWRDHEXL, FEK P TVLLPETQWNWB QWVOFN FWODTTZLRA JTBKUCSPG OCKLDKKG TCBA.